Financhill
Back

Bolt Biotherapeutics Stock Predictions

Bolt Biotherapeutics Stock Forecast

  • Is Bolt Biotherapeutics Stock Undervalued?
    The current Bolt Biotherapeutics [BOLT] share price is $1.10. The Score for BOLT is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • BOLT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Bolt Biotherapeutics Stock Go Up Next Year?

Data Unavailable

Bolt Biotherapeutics Stock Rating

Data Unavailable

Bolt Biotherapeutics Stock Price History

Is BOLT stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BOLT is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
boltbio.com

52-Week Data

52-Week High:
2.03
52-Week Low:
0.84

Prediction Charts

Market Cap:
41.94M
Price in USD:
1.10
Volume:
90.73K
Beta:
1.08

Technical Analysis

SMA50:
1.21
SMA100:
1.15
SMA200:
1.11
52-Wk Change:
-29.49%

Stock Predictions

  • Is Bolt Biotherapeutics stock public?
    Yes, Bolt Biotherapeutics is a publicly traded company.
  • What is the Bolt Biotherapeutics stock quote today?
    The Bolt Biotherapeutics stock price is 1.10 USD today.
  • How to buy Bolt Biotherapeutics stock online?
    You can buy Bolt Biotherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-12 1.25 1.18 1.28 1.17
Apr-15 1.19 1.13 1.20 1.12
Apr-16 1.15 1.15 1.15 1.08
Apr-17 1.14 1.11 1.15 1.11
Apr-18 1.14 1.14 1.16 1.11
Apr-19 1.15 1.11 1.16 1.11
Apr-22 1.11 1.11 1.13 1.09
Apr-23 1.09 1.11 1.12 1.09
Apr-24 1.10 1.20 1.21 1.09
Apr-25 1.20 1.16 1.21 1.15
Apr-26 1.20 1.11 1.20 1.10
Apr-29 1.14 1.12 1.14 1.09
Apr-30 1.10 1.11 1.13 1.10
May-1 1.12 1.10 1.13 1.08

Bolt Biotherapeutics Earnings

Data Unavailable

Bolt Biotherapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and an increase next year of $0.58 per share.

* Bolt Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.